Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Donor-Derived Cell-Free DNA Testing in Solid Organ Transplantation: A Value Proposition

2 Apr 2020

Abstract excerpt

BACKGROUND: There is a need to improve personalized immunosuppression in organ transplantation to reduce premature graft loss. More efficient biomarkers are needed to better detect rejection, asymptomatic graft injury, and under-immunosuppression. Assessment of minimal necessary exposure to guide tapering and to prevent immune activation is also important. Donor-derived cell-free DNA (dd-cfDNA) has become...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Renal Transplantation Outcomes and Treatments
Share to Transplantation: Methods and Outcomes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32447378
DOI: 10.1093/jalm/jfaa062

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Donor-Derived Cell-Free DNA Testing in Solid Organ Transplantation: A Value PropositionPMID 32447378Read ↗

Evaluation of a Decentralized Donor-Derived Cell-Free DNA Assay for Kidney Allograft Rejection MonitoringSemantic proximity Read ↗

Elevation of Donor-derived Cell-free DNA Before Biopsy-proven Rejection in Kidney TransplantSemantic proximity Read ↗

Multi‐centre analytical performance verification of an IVD assay to quantify donor‐derived cell‐free DNA in solid organ transplant recipientsSemantic proximity Read ↗

Donor-derived cell-free DNA-based liquid biopsies to determine future kidney transplant rejectionSemantic proximity Read ↗

Why Cell-Free DNA Can Be a “Game Changer” for Lung Allograft Monitoring for Rejection and InfectionSemantic proximity Read ↗

Comparison of Methods for Donor-Derived Cell-Free DNA Quantification in Plasma and Urine from Solid Organ Transplant RecipientsSemantic proximity Read ↗

Analysis of the primary factors influencing donor derived cell-free DNA testing in kidney transplantation.Semantic proximity Read ↗

Comparison of methods for donor-derived cell-free DNA quantification in plasma and urine from solid organ transplant recipientsSemantic proximity Read ↗

Myriad Applications of Circulating Cell-Free DNA in Precision Organ Transplant MonitoringSemantic proximity Read ↗

Distinct Molecular Processes Mediate Donor-derived Cell-free DNA Release From Kidney Transplants in Different Disease StatesSemantic proximity Read ↗

Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCRSemantic proximity Read ↗

Using Both Plasma and Urine Donor-Derived Cell-Free DNA to Identify Various Renal Allograft InjuriesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.